Dr. Frank Hoentjen is a Gastroenterologist and Associate Professor of Medicine, Division of Gastroenterology at the University of Alberta. He completed his residencies and GI fellowship at the Free University Medical Center, Amsterdam, completed an advanced IBD fellowship at the University of Chicago, USA, and his PhD was awarded by the Free University Medical Center, Amsterdam following a research fellowship at the University of North Carolina at Chapel Hill, USA. In 2011 he joined the Gastroenterology faculty at the Radboud University Medical Center Nijmegen, The Netherlands until 2021.
Dr. Hoentjen was director of the Inflammatory Bowel Center and director of the GI clinical trial unit at the Radboud University Medical Center Nijmegen, The Netherlands. He was chair of the Initiative on Crohn and Colitis (ICC), the Dutch national organization for IBD research. Dr. Hoentjen founded and chaired the nation-wide Dutch IBD registry, IBDREAM. He was member of the IBD committee of the Dutch National Association for Gastroenterology (NVMDL) and the Dutch national IBD guideline committee in the Netherlands. His research aims include (1) optimization of immunosuppressive and biological therapies through clinical and translational studies, and (2) achieve a better understanding of the risk of colorectal cancer and dysplasia in IBD patients and improve surveillance strategies to prevent cancer.